Polarean Imaging Plc (POLX) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.473x

Based on the latest financial reports, Polarean Imaging Plc (POLX) has a cash flow conversion efficiency ratio of -0.473x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-3.74 Million ≈ $-454.69 USD) by net assets (GBX7.90 Million ≈ $961.80 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Polarean Imaging Plc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Polarean Imaging Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Polarean Imaging Plc (POLX) financial obligations for a breakdown of total debt and financial obligations.

Polarean Imaging Plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polarean Imaging Plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
LANEBURY GROWTH CAP.
F:L01
N/A
Becket Invest Plc
LSE:TAB
N/A
Plaza Centers NV
LSE:PLAZ
0.001x
HAPPINESS DEV. GRP -01
F:2UO
N/A
PTT Global Chemical Public Company Limited
F:GCB
-0.057x
Mingzhu Logistics Holdings Ltd
NASDAQ:YGMZ
0.030x
The Generation Essentials Group
NYSE:TGE
-0.002x
Ptt PCL
STU:PTOG
0.046x

Annual Cash Flow Conversion Efficiency for Polarean Imaging Plc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Polarean Imaging Plc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see POLX stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX12.14 Million
≈ $1.48K
GBX-4.17 Million
≈ $-507.80
-0.344x +72.67%
2023-12-31 GBX8.30 Million
≈ $1.01K
GBX-10.43 Million
≈ $-1.27K
-1.257x -98.04%
2022-12-31 GBX19.30 Million
≈ $2.35K
GBX-12.26 Million
≈ $-1.49K
-0.635x -64.50%
2021-12-31 GBX31.74 Million
≈ $3.86K
GBX-12.25 Million
≈ $-1.49K
-0.386x +41.83%
2020-12-31 GBX8.73 Million
≈ $1.06K
GBX-5.79 Million
≈ $-705.05
-0.664x +33.29%
2019-12-31 GBX4.59 Million
≈ $558.48
GBX-4.57 Million
≈ $-555.51
-0.995x -65.73%
2018-12-31 GBX7.79 Million
≈ $947.99
GBX-4.68 Million
≈ $-568.98
-0.600x +21.06%
2017-12-31 GBX3.44 Million
≈ $418.60
GBX-2.62 Million
≈ $-318.25
-0.760x -158.60%
2016-12-31 GBX-585.75K
≈ $-71.27
GBX-759.99K
≈ $-92.47
1.297x --

About Polarean Imaging Plc

LSE:POLX UK Medical Devices
Market Cap
$11.75K
GBX96.56 Million GBX
Market Cap Rank
#31285 Global
#1289 in UK
Share Price
GBX0.08
Change (1 day)
-20.00%
52-Week Range
GBX0.08 - GBX1.45
All Time High
GBX106.50
About

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more